Montgomery et al. find that U.S. cannabis legalisation reduced overall drug seizures, but racial disparities persisted, underscoring the need for more systemic change.
The Forum urged periodic HRC resolutions, stronger UN coordination, an operational expert panel, and sustained harm reduction funding, highlighting Indigenous rights, decriminalisation, and civil society inclusion as key priorities.
Mulcahy et al. explore whether stigma constitutes cruel, inhuman, and degrading treatment, outlining possibilities for viable legal claims on the basis of human rights.
UNAIDS warns that a global funding crisis threatens decades of HIV progress, despite the resilience of communities sustaining gains and domestic innovation.
The Harm Reduction Coalition and the Academy of Perinatal Harm Reduction offer a toolkit to support the health and well-being of pregnant people who use drugs and their families.
For the first time, a UN human rights body urges Canada to expand safe supply and end coercive drug treatment. The CRPD committee calls for voluntary, community-based care that respects autonomy and legal capacity in mental health and addiction.
A new UNAIDS–ILO report lays out urgent reforms in relation to the Joint Programme's management, warning of resurgence risks without stronger country leadership, civil society involvement, domestic investment, and forecasting the pandemic's progress.
The 2025 EU Drug Report uncovers a rapidly evolving drug landscape, fuelled by synthetic substances, tech innovation, and global instability. With rising health and security threats, the report places urgent emphasis on real-time data, early warning systems, and bold cross-sector collaboration.
Published 14 May 2025, WHO’s new guidance calls for bold, balanced drug policies that ensure fair access to controlled medicines. It updates 2011 rules with sharper focus on equity, harm reduction, pricing, regulation, and education - anchored in health rights and transparency.
